Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 01, 2019 07:30 ET | Source: Otonomy, Inc.

AGTC and Otonomy Announce Strategic Collaboration to Develop and Commercialize Gene Therapy for Congenital Hearing Loss

GAINESVILLE, Fla. and CAMBRIDGE, Mass. and SAN DIEGO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical...
September 26, 2019 16:05 ET | Source: Otonomy, Inc.

Otonomy to Present at the Cantor Global Healthcare Conference

SAN DIEGO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that...
September 17, 2019 07:30 ET | Source: Otonomy, Inc.

Otonomy Initiating Phase 1/2 Clinical Trial of OTO-413 in Hearing Loss

SAN DIEGO, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...
August 01, 2019 16:20 ET | Source: Otonomy, Inc.

Otonomy Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Clinical-stage programs on track with results expected from three trials in 2020Current capital funds operations into 2021 Conference call and webcast today at 4:30 p.m. EDT SAN DIEGO, Aug. 01,...
July 25, 2019 16:05 ET | Source: Otonomy, Inc.

Otonomy to Report Second Quarter 2019 Financial Results and Provide Corporate Update

SAN DIEGO, July 25, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...
June 12, 2019 08:00 ET | Source: Otonomy, Inc.

Otonomy to Present at the Raymond James Life Sciences and MedTech Conference

SAN DIEGO, June 12, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that...
February 06, 2018 07:30 ET | Source: Otonomy, Inc.

Otonomy Announces Multiple Presentations for Hearing Loss and Tinnitus Programs at Upcoming Association for Research in Otolaryngology Meeting

SAN DIEGO, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced seven data...